Recent Press Releases

Universal Health Services, Inc. Reports 2014 Fourth Quarter And Full Year Earnings And 2015 Earnings Guidance

Consolidated Results of Operations, As Reported - Three and twelve-month periods ended December 31, 2014 and 2013:

KING OF PRUSSIA, Pa.

Johnson & Johnson Announces Formation of New Health and Wellness Platform Designed to Transform Health Care Delivery and Improve the Patient Experience

New Patient Athlete™ Program Demonstrates Comprehensive Approach to Driving Sustained Behavior Change and Improved Outcomes

NEW BRUNSWICK

Launch of the Anti-Cancer Agent / BRAF Inhibitor "Zelboraf®" - Contribution to the Treatment of Melanoma by Personalized Healthcare -

February 25, 2015 (Tokyo) - Chugai Pharmaceutical Co., Ltd. [Main Office: Chuo-ku, Tokyo. Chairman & CEO: Osamu Nagayama (hereafter, "Chugai")] announced today that it will launch the BRAF...

NICE guidance recommends sofosbuvir (Sovaldi, Gilead Sciences) and simeprevir (Olysio, Janssen) for treating hepatitis C

Healthcare guidance body NICE has today published final guidance recommending sofosbuvir (Sovaldi, Gilead Sciences) and simeprevir (Olysio, Janssen) as treatment options for some people with chronic...

SANOFI RECEIVES FDA APPROVAL OF ONCE-DAILY BASAL INSULIN TOUJEO®

PARIS, Feb. 25, 2015 /PRNewswire-USNewswire/ -- Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL), a...

Assemblymember Chiu Introduces Bill to Lift Veil on Drug Pricing

Assemblymember Chiu Introduces Bill to Lift Veil on Drug Pricing Proposal Requires Transparency on Drug Costs for First Time Assemblymember David Chiu (D- San Francisco) introduced AB 463, which, for...

Lilly to Present at Cowen Health Care Conference

INDIANAPOLIS, Feb.

ABRAXANE® Now Reimbursed in Italy as a First-Line Treatment of Adult Patients with Metastatic Pancreatic Cancer

BOUDRY, Switzerland--(BUSINESS WIRE)-- Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (CELG), today announced that Italian authorities have issued a positive...

TWi Pharmaceuticals Announces That It Will Sell Its Products in the U.S. Market, Originally Planned to Be Sold by Teva, Through Its Wholly-Owned Subsidiary, TWi Pharmaceuticals USA

TAIPEI, Feb. 23, 2015 /PRNewswire/ -- TWi Pharmaceuticals, Inc. ("TWi") (4180:Taiwan) today announced that TWi and Teva Pharmaceuticals ("Teva") have reached an agreement that...

Antifungal Treatment Should Be Taken Off the Market, Public Citizen Tells FDA

Ketoconazole Offers No Unique Benefits, Only Unique Risks Compared With Other, Safer Antifungals, According to FDA's Own Experts Note: This release and the petition refer only to the oral...

Takeda to Acquire Select Portfolio from Neutec, Significantly Enhancing its Business in Turkey

Takeda to Acquire Select Portfolio from Neutec, Significantly Enhancing its Business in Turkey Acquisition to strengthen Takeda's strategic position in Turkey, adding complementary products to...

Baxter U.S. Selects Bannockburn, Ill., Facility as Location for Baxalta Global Headquarters

Separation into Two Publicly Traded Companies Remains on Track for Mid-2015 DEERFIELD, Ill., FEBRUARY 23, 2015 - Baxter International Inc. (NYSE:BAX) announced today that Baxalta Incorporated, the...

NASCAR Driver Ryan Reed Takes First Place At Daytona International Speedway

On and off the track, Reed shows that diabetes doesn't stop him from living his dreams

INDIANAPOLIS and

FDA Accepts Supplemental New Drug Application for Priority Review of RAPAMUNE® (sirolimus) for Treatment of Lymphangioleiomyomatosis (LAM)

NEW YORK, NY, USA I February 20, 2015 I Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority review a supplemental New Drug Application...